English
简体中文
Total: £ 56.28
Published Date: 2025-05-06 | Pages: 76 | Tables: 73 | Pharma & Healthcare
The global market for Rivaroxaban was valued at US$ 9349 million in the year 2024 and is projected to reach a revised size of US$ 16110 million by 2031, growing at a CAGR of 8.2% during the forecast period.
Rivaroxaban is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it is marketed by Janssen Pharmaceutica. It is the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects last approximately 8–12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible.
The major players in global Prom Dresses market include Bayer, Johnson and Johnson, etc. The top 2 players occupy nearly 100% of the market. Europe is the main market, and occupies nearly 100% of the global market. 10 mg is the main type, with a share over 30%. Venous Thromboembolism (VTE) is the main application, which holds a share about 85%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Rivaroxaban, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rivaroxaban.
The Rivaroxaban market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rivaroxaban market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rivaroxaban manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Bayer
J&J
Segment by Type
2.5 mg
10 mg
15 mg
20 mg
Segment by Application
Acute Coronary Syndrome (ACS)
Venous Thromboembolism (VTE)
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rivaroxaban manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Rivaroxaban in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Rivaroxaban Market Overview
1.1 Product Definition
1.2 Rivaroxaban by Type
1.2.1 Global Rivaroxaban Market Value Comparison by Type (2024 VS 2031)
1.2.2 2.5 mg
1.2.3 10 mg
1.2.4 15 mg
1.2.5 20 mg
1.3 Rivaroxaban by Application
1.3.1 Global Rivaroxaban Market Value by Application (2024 VS 2031)
1.3.2 Acute Coronary Syndrome (ACS)
1.3.3 Venous Thromboembolism (VTE)
1.4 Global Rivaroxaban Market Size Estimates and Forecasts
1.4.1 Global Rivaroxaban Revenue 2020-2031
1.4.2 Global Rivaroxaban Sales 2020-2031
1.4.3 Global Rivaroxaban Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Rivaroxaban Market Competition by Manufacturers
2.1 Global Rivaroxaban Sales Market Share by Manufacturers (2020-2025)
2.2 Global Rivaroxaban Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Rivaroxaban Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Rivaroxaban, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Rivaroxaban, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rivaroxaban, Product Type & Application
2.7 Global Key Manufacturers of Rivaroxaban, Date of Enter into This Industry
2.8 Global Rivaroxaban Market Competitive Situation and Trends
2.8.1 Global Rivaroxaban Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Rivaroxaban Players Market Share by Revenue
2.8.3 Global Rivaroxaban Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Rivaroxaban Market Scenario by Region
3.1 Global Rivaroxaban Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Rivaroxaban Sales by Region: 2020-2031
3.2.1 Global Rivaroxaban Sales by Region: 2020-2025
3.2.2 Global Rivaroxaban Sales by Region: 2026-2031
3.3 Global Rivaroxaban Revenue by Region: 2020-2031
3.3.1 Global Rivaroxaban Revenue by Region: 2020-2025
3.3.2 Global Rivaroxaban Revenue by Region: 2026-2031
3.4 North America Rivaroxaban Market Facts & Figures by Country
3.4.1 North America Rivaroxaban Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Rivaroxaban Sales by Country (2020-2031)
3.4.3 North America Rivaroxaban Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Rivaroxaban Market Facts & Figures by Country
3.5.1 Europe Rivaroxaban Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Rivaroxaban Sales by Country (2020-2031)
3.5.3 Europe Rivaroxaban Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rivaroxaban Market Facts & Figures by Region
3.6.1 Asia Pacific Rivaroxaban Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Rivaroxaban Sales by Region (2020-2031)
3.6.3 Asia Pacific Rivaroxaban Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Rivaroxaban Market Facts & Figures by Country
3.7.1 Latin America Rivaroxaban Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Rivaroxaban Sales by Country (2020-2031)
3.7.3 Latin America Rivaroxaban Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rivaroxaban Market Facts & Figures by Country
3.8.1 Middle East and Africa Rivaroxaban Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Rivaroxaban Sales by Country (2020-2031)
3.8.3 Middle East and Africa Rivaroxaban Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Rivaroxaban Sales by Type (2020-2031)
4.1.1 Global Rivaroxaban Sales by Type (2020-2025)
4.1.2 Global Rivaroxaban Sales by Type (2026-2031)
4.1.3 Global Rivaroxaban Sales Market Share by Type (2020-2031)
4.2 Global Rivaroxaban Revenue by Type (2020-2031)
4.2.1 Global Rivaroxaban Revenue by Type (2020-2025)
4.2.2 Global Rivaroxaban Revenue by Type (2026-2031)
4.2.3 Global Rivaroxaban Revenue Market Share by Type (2020-2031)
4.3 Global Rivaroxaban Price by Type (2020-2031)
5 Segment by Application
5.1 Global Rivaroxaban Sales by Application (2020-2031)
5.1.1 Global Rivaroxaban Sales by Application (2020-2025)
5.1.2 Global Rivaroxaban Sales by Application (2026-2031)
5.1.3 Global Rivaroxaban Sales Market Share by Application (2020-2031)
5.2 Global Rivaroxaban Revenue by Application (2020-2031)
5.2.1 Global Rivaroxaban Revenue by Application (2020-2025)
5.2.2 Global Rivaroxaban Revenue by Application (2026-2031)
5.2.3 Global Rivaroxaban Revenue Market Share by Application (2020-2031)
5.3 Global Rivaroxaban Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Company Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Rivaroxaban Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bayer Rivaroxaban Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 J&J
6.2.1 J&J Company Information
6.2.2 J&J Description and Business Overview
6.2.3 J&J Rivaroxaban Sales, Revenue and Gross Margin (2020-2025)
6.2.4 J&J Rivaroxaban Product Portfolio
6.2.5 J&J Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rivaroxaban Industry Chain Analysis
7.2 Rivaroxaban Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rivaroxaban Production Mode & Process Analysis
7.4 Rivaroxaban Sales and Marketing
7.4.1 Rivaroxaban Sales Channels
7.4.2 Rivaroxaban Distributors
7.5 Rivaroxaban Customer Analysis
8 Rivaroxaban Market Dynamics
8.1 Rivaroxaban Industry Trends
8.2 Rivaroxaban Market Drivers
8.3 Rivaroxaban Market Challenges
8.4 Rivaroxaban Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Rivaroxaban Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Rivaroxaban Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Rivaroxaban Market Competitive Situation by Manufacturers in 2024
Table 4. Global Rivaroxaban Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Rivaroxaban Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Rivaroxaban Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Rivaroxaban Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Rivaroxaban Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Rivaroxaban, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Rivaroxaban, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Rivaroxaban, Product Type & Application
Table 12. Global Key Manufacturers of Rivaroxaban, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Rivaroxaban by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rivaroxaban as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Rivaroxaban Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Rivaroxaban Sales by Region (2020-2025) & (K Units)
Table 18. Global Rivaroxaban Sales Market Share by Region (2020-2025)
Table 19. Global Rivaroxaban Sales by Region (2026-2031) & (K Units)
Table 20. Global Rivaroxaban Sales Market Share by Region (2026-2031)
Table 21. Global Rivaroxaban Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Rivaroxaban Revenue Market Share by Region (2020-2025)
Table 23. Global Rivaroxaban Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Rivaroxaban Revenue Market Share by Region (2026-2031)
Table 25. North America Rivaroxaban Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Rivaroxaban Sales by Country (2020-2025) & (K Units)
Table 27. North America Rivaroxaban Sales by Country (2026-2031) & (K Units)
Table 28. North America Rivaroxaban Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Rivaroxaban Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Rivaroxaban Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Rivaroxaban Sales by Country (2020-2025) & (K Units)
Table 32. Europe Rivaroxaban Sales by Country (2026-2031) & (K Units)
Table 33. Europe Rivaroxaban Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Rivaroxaban Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Rivaroxaban Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Rivaroxaban Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Rivaroxaban Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Rivaroxaban Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Rivaroxaban Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Rivaroxaban Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Rivaroxaban Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Rivaroxaban Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Rivaroxaban Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Rivaroxaban Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Rivaroxaban Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Rivaroxaban Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Rivaroxaban Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Rivaroxaban Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Rivaroxaban Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Rivaroxaban Sales (K Units) by Type (2020-2025)
Table 51. Global Rivaroxaban Sales (K Units) by Type (2026-2031)
Table 52. Global Rivaroxaban Sales Market Share by Type (2020-2025)
Table 53. Global Rivaroxaban Sales Market Share by Type (2026-2031)
Table 54. Global Rivaroxaban Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Rivaroxaban Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Rivaroxaban Revenue Market Share by Type (2020-2025)
Table 57. Global Rivaroxaban Revenue Market Share by Type (2026-2031)
Table 58. Global Rivaroxaban Price (USD/Unit) by Type (2020-2025)
Table 59. Global Rivaroxaban Price (USD/Unit) by Type (2026-2031)
Table 60. Global Rivaroxaban Sales (K Units) by Application (2020-2025)
Table 61. Global Rivaroxaban Sales (K Units) by Application (2026-2031)
Table 62. Global Rivaroxaban Sales Market Share by Application (2020-2025)
Table 63. Global Rivaroxaban Sales Market Share by Application (2026-2031)
Table 64. Global Rivaroxaban Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Rivaroxaban Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Rivaroxaban Revenue Market Share by Application (2020-2025)
Table 67. Global Rivaroxaban Revenue Market Share by Application (2026-2031)
Table 68. Global Rivaroxaban Price (USD/Unit) by Application (2020-2025)
Table 69. Global Rivaroxaban Price (USD/Unit) by Application (2026-2031)
Table 70. Bayer Company Information
Table 71. Bayer Description and Business Overview
Table 72. Bayer Rivaroxaban Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Bayer Rivaroxaban Product
Table 74. Bayer Recent Developments/Updates
Table 75. J&J Company Information
Table 76. J&J Description and Business Overview
Table 77. J&J Rivaroxaban Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. J&J Rivaroxaban Product
Table 79. J&J Recent Developments/Updates
Table 80. Key Raw Materials Lists
Table 81. Raw Materials Key Suppliers Lists
Table 82. Rivaroxaban Distributors List
Table 83. Rivaroxaban Customers List
Table 84. Rivaroxaban Market Trends
Table 85. Rivaroxaban Market Drivers
Table 86. Rivaroxaban Market Challenges
Table 87. Rivaroxaban Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
Table 91. Authors List of This Report
List of Figures
Figure 1. Product Picture of Rivaroxaban
Figure 2. Global Rivaroxaban Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Rivaroxaban Market Share by Type: 2024 & 2031
Figure 4. 2.5 mg Product Picture
Figure 5. 10 mg Product Picture
Figure 6. 15 mg Product Picture
Figure 7. 20 mg Product Picture
Figure 8. Global Rivaroxaban Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Rivaroxaban Market Share by Application: 2024 & 2031
Figure 10. Acute Coronary Syndrome (ACS)
Figure 11. Venous Thromboembolism (VTE)
Figure 12. Global Rivaroxaban Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Rivaroxaban Market Size (2020-2031) & (US$ Million)
Figure 14. Global Rivaroxaban Sales (2020-2031) & (K Units)
Figure 15. Global Rivaroxaban Average Price (USD/Unit) & (2020-2031)
Figure 16. Rivaroxaban Report Years Considered
Figure 17. Rivaroxaban Sales Share by Manufacturers in 2024
Figure 18. Global Rivaroxaban Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Rivaroxaban Players: Market Share by Revenue in Rivaroxaban in 2024
Figure 20. Rivaroxaban Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Rivaroxaban Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Rivaroxaban Sales Market Share by Country (2020-2031)
Figure 23. North America Rivaroxaban Revenue Market Share by Country (2020-2031)
Figure 24. U.S. Rivaroxaban Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Rivaroxaban Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Rivaroxaban Sales Market Share by Country (2020-2031)
Figure 27. Europe Rivaroxaban Revenue Market Share by Country (2020-2031)
Figure 28. Germany Rivaroxaban Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Rivaroxaban Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Rivaroxaban Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Rivaroxaban Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Rivaroxaban Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Rivaroxaban Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Rivaroxaban Revenue Market Share by Region (2020-2031)
Figure 35. China Rivaroxaban Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Rivaroxaban Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Rivaroxaban Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Rivaroxaban Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Rivaroxaban Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Rivaroxaban Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Rivaroxaban Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Rivaroxaban Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Rivaroxaban Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Rivaroxaban Sales Market Share by Country (2020-2031)
Figure 45. Latin America Rivaroxaban Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Rivaroxaban Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Rivaroxaban Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Rivaroxaban Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Rivaroxaban Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Rivaroxaban Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Rivaroxaban Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Rivaroxaban Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Rivaroxaban Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Rivaroxaban by Type (2020-2031)
Figure 55. Global Revenue Market Share of Rivaroxaban by Type (2020-2031)
Figure 56. Global Rivaroxaban Price (USD/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Rivaroxaban by Application (2020-2031)
Figure 58. Global Revenue Market Share of Rivaroxaban by Application (2020-2031)
Figure 59. Global Rivaroxaban Price (USD/Unit) by Application (2020-2031)
Figure 60. Rivaroxaban Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
